Lista de obras - Luis J Leandro-García - Dominio Público Uruguay

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

artículo científico publicado en 2010

Comparative analysis of Drosophila melanogaster and Caenorhabditis elegans gene expression experiments in the European Soyuz flights to the International Space Station.

artículo científico publicado en 2007

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

artículo científico publicado en 2016

Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

artículo científico publicado en 2012

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

artículo científico publicado en 2011

Functional and in silico assessment of MAX variants of unknown significance

artículo científico publicado en 2015

Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients.

artículo científico publicado en 2012

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

artículo científico publicado en 2009

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

scientific journal article

Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

artículo científico publicado en 2012

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

artículo científico publicado en 2019

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways

artículo científico publicado en 2013

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

artículo científico publicado en 2007

Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome

artículo científico publicado en 2020

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma

artículo científico publicado en 2020

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

artículo científico publicado en 2010

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.

artículo científico publicado en 2013

Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.

artículo científico publicado en 2009

Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.

artículo científico publicado en 2012

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

artículo científico publicado en 2010

SDHC mutation in an elderly patient without familial antecedents.

artículo científico publicado en 2008

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

article

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

artículo científico publicado en 2010

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

artículo científico publicado en 2017

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

artículo científico publicado en 2013

VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.

artículo científico publicado en 2014

Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy

artículo científico publicado en 2014

Lista de obras de Luis J Leandro-García

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

Comparative analysis of Drosophila melanogaster and Caenorhabditis elegans gene expression experiments in the European Soyuz flights to the International Space Station.

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

Functional and in silico assessment of MAX variants of unknown significance

Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients.

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.

Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.

Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

SDHC mutation in an elderly patient without familial antecedents.

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.

Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy